The U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine.
FDA limits use of Janssen COVID-19 vaccine to certain individuals
May 8, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022